Por Renan Filho · 2026-10-21**Lead**
The NFL’s most senior medical official has publicly backed the Philadelphia Eagles’ medical staff in their handling of quarterback Jalen Hurts’ recent diagnosis of deep-vein thrombosis (DVT), insisting the team acted “appropriately and expeditiously.” But the NFL Players Association (NFLPA) is pushing back, arguing that the Eagles failed to promptly inform Hurts and his representatives about the full nature of the blood clots, raising questions about player safety protocols and trust between franchises and their athletes.
The conflicting accounts emerged during a contentious week in which Hurts was sidelined indefinitely after a routine postgame check revealed a clot in his lower leg. The condition, while treatable, carries significant risks if not managed correctly, including the potential for pulmonary embolism. Dr. Allen Sills, the NFL’s chief medical officer, told reporters during a conference call that the league’s medical committee reviewed the Eagles’ internal procedures and found no deviation from established standards of care. “The team acted on the information as it became available, and the player received appropriate treatment in a timely manner,” Sills said.
**Context**
Jalen Hurts, 28, has been a cornerstone of the Eagles’ offense since taking over as starter in 2021. He led the team to a Super Bowl appearance two seasons ago and has been widely praised for his toughness and durability. The DVT diagnosis first became public when ESPN reported that Hurts had been placed on blood-thinning medication and would be out indefinitely. The Eagles later confirmed the news but offered few details about the timeline, stating only that the condition was discovered during “routine medical monitoring.”
The NFLPA, which represents players in matters of health and safety, quickly criticized the franchise for what it described as a lack of transparency. According to sources familiar with the union’s internal review, Hurts first reported mild leg soreness after a Week 5 victory, but the team’s athletic trainers did not order an ultrasound until nearly 48 hours later, after the quarterback complained of swelling. The union contends that the delay could have allowed the clot to grow or migrate, increasing the risk of serious complications.
“The player was not given full information about the diagnosis until after the union intervened,” a senior NFLPA official told The Athletic, speaking on condition of anonymity because the investigation is ongoing. “There’s a pattern here. Players are being kept in the dark about their own bodies, and that’s unacceptable.” The union has requested a formal review of the Eagles’ medical records related to Hurts and has signaled it may file a grievance if the review shows negligence.
**Analyse**
The dispute between the NFL and its players’ union over the handling of Hurts’ condition is emblematic of a broader tension that has simmered for years. While the league has invested heavily in injury prevention and treatment protocols, players and advocates argue that team-employed medical staff face inherent conflicts of interest. Doctors and trainers are paid by the organization, creating what critics describe as a built-in incentive to prioritize a player’s return to the field over long-term health.
Dr. Sills defended the current system, noting that independent medical observers are present at games and that all diagnoses are shared with the NFLPA’s medical director. He declined to comment specifically on the Eagles’ internal log, citing confidentiality, but stated that “the structure in place is designed to catch issues like this. When there are questions, we look at the data, and we make changes if necessary.”
The Hurts case has also sparked discussion about how DVT is managed in elite athletes. Unlike soft-tissue injuries, blood clots can be life-threatening and require immediate, precise care. The standard treatment involves anticoagulants, which force players to avoid contact sports for weeks or months. That means Hurts’ season is almost certainly over, a devastating blow for a team that entered the year with championship aspirations. The Eagles currently sit at 3–3 and face a critical stretch without their franchise quarterback.
**Impact and broader implications**
For the NFLPA, this incident is more than just a medical dispute; it is leverage for the next round of collective bargaining. The union has long demanded that team medical decisions be made by independent physicians, not employees of the franchise. While the league has pushed back, arguing that team doctors have the most direct knowledge of a player’s history and physical condition, cases like Hurts’ could shift public and political pressure toward greater oversight. Senator Richard Blumenthal (D-CT) has already written to NFL Commissioner Roger Goodell requesting a full briefing on the matter, citing the league’s “obligation to protect the health of its workers.”
For now, Hurts is reportedly at home resting and responding well to treatment. His camp has issued a statement thanking fans for their support and expressing confidence in the medical team, though notably stopping short of endorsing the Eagles’ handling of the timeline. The NFLPA’s investigation is expected to conclude within the next month, and its findings could influence not only Hurts’ case but also future policies on how blood clots and other silent conditions are identified and disclosed across the league.
**Fontes**
- Dr. Allen Sills, NFL Chief Medical Officer, conference call remarks, Oct. 20, 2026. - The Athletic, report on NFLPA internal review, Oct. 20, 2026. - ESPN, initial report on Jalen Hurts’ DVT diagnosis, Oct. 18, 2026. - Senator Richard Blumenthal (D-CT), letter to NFL Commissioner Roger Goodell, Oct. 21, 2026.